Ascensia Diabetes Care Holdings AG

Ascensia Diabetes Care is a global medical device company specializing in blood glucose monitoring systems and diabetes management solutions. The company's primary product portfolio centers on the CONTOUR® brand of blood glucose monitoring systems, which are designed to provide advanced accuracy and user-friendly functionality for patients managing diabetes. The CONTOUR® NEXT line represents their flagship offering, featuring advanced technology for reliable glucose measurement and data tracking. In addition to hardware monitoring devices, Ascensia offers integrated diabetes management solutions that enable patients to track results and monitor trends over time. The company operates as a global organization with local market presence through regional websites and distributors. Ascensia is part of the PHC Group, which has implemented a comprehensive ESG (environmental, social, and governance) strategy aligned with global sustainability goals. The company is committed to innovation in diabetes care and serves patients through both consumer-facing products and healthcare provider channels. Their manufacturing and regulatory compliance aligns with international standards for in vitro diagnostic devices used in point-of-care glucose monitoring applications.